Director of Public Policy Europe & Canada, MSD
Boris Azaïs is currently Director, Public Policy Europe & Canada for MSD (a subsidiary of Merck & Co., Inc.). In his capacity, Boris Azaïs interacts with European institutions and governments focusing on industrial policy, competitiveness and innovation in Europe and Canada. He speaks at international conferences, produces position papers, and promotes dialogue between health and industry stakeholders to foster a policy framework that enables pharmaceutical innovation. Boris Azaïs has spent part of his career in Geneva and in Middle-East & Africa countries. Boris Azaïs is a member of the Advisory Board of Pharmaceutical Executive, a leading publication for the pharmaceutical industry.